Close
What would you like to look for?
Search filters

Memo Therapeutics AG Increases Series C Financing to CHF 45m

15 May 2024

Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.

Narrowin and EnBW enter partnership

15 April 2024

The German energy supplier EnBW enters into a partnership with narrowin GmbH, a Swiss cybersecurity start-up. As part of the cooperation, EnBW is also making a financial investment in narrowin via EnPulse Ventures GmbH.

Oculis completes $59m Share Placemement and Listing on Nasdaq Iceland

15 April 2024

Oculis Holding AG (Nasdaq: OCS) completed a financing of approximately $59 million, consisting of the issuance of 5,000,000 of its ordinary shares at a purchase price of $11.75 per share.

Odne completes financing round

18 March 2024

Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch for their minimal invasive Root Preservation Technology (RPT).

Artiria Medical SA raises USD 6m in a Series A2 Financing Round

1 March 2024

Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation neuro-interventional products for stroke and aneurysms, closed a USD 6m series A2 financing round.

Sale of Iconia Group to Deutsche Invest

12 February 2024

AFINUM and the management have sold Iconia Group to Deutsche Invest. Iconia Group is a global leader in point-of-purchase displays and packaging for the watch and jewelry industry. The transaction was completed on 31 January 2024.

EraCal Therapeutics AG to license certain assets to Novo Nordisk

31 January 2024

EraCal Therapeutics AG ("EraCal"), a Swiss biotech start-up company focusing on the fight of obesity has licensed certain assets to Novo Nordisk for a total amount of EUR 235m in a collaboration and license deal.

GlycoEra AG increases its Series A Financing Round with investment by BMS

22 January 2024

GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional investment by Bristol Meyer Squibb (BMS).

Alex Frei becomes a shareholder and board member at DuBois et fils

17 January 2024

Alex Frei, footballer, coach and record goalscorer for the Swiss national team, has acquired a stake in the watch brand DuBois et fils, which has been based in Basel since 2012.

VISCHER advises DomoHealth on Series C Financing Round

16 January 2024

DomoHealth SA, a leading company in the digital health segment developing innovative solutions in the field of patient safety, announced the successful closing of its Series C financing round.